Director's Dealing • Mar 13, 2024
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 7446G
Trifast PLC
13 March 2024

Wednesday, 13 March 2024
Trifast plc
(the "Company")
Director/PDMR shareholding
The Company announces that on Tuesday 12 March 2024, the spouse of Mr. Louis Eperjesi, Non-Executive Director, purchased a total of 13,000 ordinary shares of 5 pence each in the Company ("Ordinary Shares") . Following this transaction, Mr. Eperjesi and Persons Closely associated with him have a beneficial interest of 13,000 Ordinary Shares in the Company.
The notifications below are made in accordance with the requirements of the EU Market Abuse Regulation.
1.
Details of the person discharging managerial responsibilities / person closely associated
a.
Name
L ouis Eperjesi
2.
Reason for the notification
a.
Position/status
Non-Executive Director
b.
Initial notification/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.
Name
Trifast plc
b.
LEI
213800WFIVE6RWK3CR22
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.
Description of the financial instrument, type of instrument Identification code
Ordinary shares of 5 pence each
GB0008883927
b.
Nature of the transaction
Purchase of shares by the spouse of Louis Eperjesi
c.
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 76.372p | 13,000 |
d.
Aggregated information
· Aggregated volume
· Price
13,000
76.372p
e.
Date of the transaction
12 March 2024
f.
Place of the transaction
London Stock Exchange, Main Market (XLON)
Enquiries:
Trifast plc
Christopher Morgan
Company Secretary
Tel: +44 (0) 1825 769696
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHZZGMFDFRGDZM
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.